Drupacine as a potent SARS-CoV-2 replication inhibitor in vitro
Despite the availability of vaccines and antiviral treatments, the continued emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and breakthrough infections underscores the need for new, potent antiviral therapies. In a previous study, we established a transcription an...
Saved in:
Main Authors: | Chen Yang (Author), Yanying Yu (Author), Qi Peng (Author), Jingwei Song (Author), Bo Sun (Author), Yi Shi (Author), Qiang Ding (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
by: Jerneja Kladnik, et al.
Published: (2022) -
Losartan Inhibits SARS-CoV-2 Replication in Vitro
by: Reza Nejat, et al.
Published: (2021) -
QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
by: Fucheng Song, et al.
Published: (2023) -
SARS-CoV-2 virus: origin, structure and replication cycle
by: Katarzyna Kuczyńska, et al.
Published: (2021) -
Replication and Injury Associated With SARS-CoV-2 in Cultured Hepatocytes
by: Suman Pradhan, et al.
Published: (2024)